Articles

Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell types

Institute for Molecular Medicine Finland FIMM, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
Institute for Molecular Medicine Finland FIMM, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
Hematology Section, Department of Internal Medicine, Haukeland University Hospital, Bergen, Norway
Department of Biology, National University of Ireland, Maynooth, Ireland
Institute for Molecular Medicine Finland FIMM, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Hematology, Mater Misericordiae University Hospital, Dublin, Ireland
Department of Clinical Chemistry and Hematology, University of Helsinki, Finland
Institute for Molecular Medicine Finland FIMM, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
Institute for Molecular Medicine Finland FIMM, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
Institute for Molecular Medicine Finland FIMM, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland;Science for Life Laboratory, Department of Oncology and Pathology, Karolinska Institute, Solna, Sweden
Department of Clinical Chemistry and Hematology, University of Helsinki, Finland;Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland
Department of Hematology, Mater Misericordiae University Hospital, Dublin, Ireland
Institute for Molecular Medicine Finland FIMM, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland;BRIC-Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark
Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland;Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
Hematology Section, Department of Internal Medicine, Haukeland University Hospital, Bergen, Norway;Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway
Institute for Molecular Medicine Finland FIMM, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
Vol. 105 No. 6 (2020): June, 2020 https://doi.org/10.3324/haematol.2019.217414